The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase
Abstract
Murine dendritic cells (DCs) expressing indoleamine 2,3 dioxygenase (IDO) catabolize tryptophan and can suppress T cell responses elicited in vivo. Here, we identify specific subsets of splenic (CD11c+) dendritic cells competent to mediate IDO-dependent T cell suppression following CTLA4-mediated ligation of B7 molecules. IDO-competent DC subsets acquired potent and dominant T cell suppressive properties as a consequence of IDO up-regulation, as they blocked the ability of T cells to respond to other stimulatory DCs in the same cultures. Soluble CTLA4 (CTLA4-Ig) and cloned CTLA4+ regulatory T cells (Tr1D1) up-regulated IDO selectively in DC subsets co-expressing B220 or CD8alpha. The ability of Tr1D1 T cells to suppress CD8+ T cell responses was completely dependent on their ability to induce tryptophan catabolism in DCs. Selective IDO up-regulation in DCs did not inhibit T cell activation, but prevented T cell clonal expansion due to rapid death of activated T cells. T cell responses were restored by genetic or pharmacologic inhibition of IDO enzyme activity, or by adding excess tryptophan. DCs from interferon gamma (IFNgamma)-receptor-deficient mice were effective in promoting IDO-dependent T cell suppression following CTLA4-Ig exposure in vivo, indicating that IFNgamma signaling was not necessary for IDO up-regulation in this model. These findings suggest that IDO-competent DCs provide a regulatory bridge, mediated by CTLA4-B7 engagement, between certain regulatory T cell subsets and naive responder T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Di Rosa, F., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,342
Mouse and human dendritic cell subtypes
Shortman, K., & Liu, Y.-J. (2002) · Nature Reviews Immunology · doi:10.1038/nri746 · Cited by 2,291
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Self-citationModulation of tryptophan catabolism by regulatory T cells
Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M.-L., & Puccetti, P. (2003) · Nature Immunology · doi:10.1038/ni1003 · Cited by 1,374
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
Steinman, R. M., & Nussenzweig, M. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231606698 · Cited by 1,166
CTLA-4–Ig regulates tryptophan catabolism in vivo
Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M. L., Bianchi, R., Fioretti, M. C., et al. (2002) · Nature Immunology · doi:10.1038/ni846 · Cited by 1,161
Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., & Ferrara, G. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020121 · Cited by 1,133
Relationship between interferon‐γ, indoleamine 2,3‐dioxygenase, and tryptophan catabolism
Taylor, M. W., & Feng, G. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.11.1907934 · Cited by 1,060
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., et al. (2002) · Science · doi:10.1126/science.1073514 · Cited by 1,028
Self-citationT cell apoptosis by tryptophan catabolism
Fallarino, F., Grohmann, U., Vacca, C., Bianchi, R., Orabona, C., Spreca, A., Fioretti, M. C., & Puccetti, P. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401073 · Cited by 1,022
Terness, P., Bauer, T. M., Röse, L., Dufter, C., Watzlik, A., Simon, H., & Opelz, G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020052 · Cited by 937
Wakkach, A., Fournier, N., Brun, V., Breittmayer, J.-P., Cottrez, F., & Groux, H. (2003) · Immunity · doi:10.1016/s1074-7613(03)00113-4 · Cited by 788
Tolerance, DCs and tryptophan: much ado about IDO
Grohmann, U. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00072-3 · Cited by 766
Hwu, P., Du, M. X., Lapointe, R., Do, M., Taylor, M. W., & Young, H. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3596 · Cited by 739
Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?
Mellor, A. L., & Munn, D. H. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01520-0 · Cited by 648
Self-citationGilliet, M., Boonstra, A., Paturel, C., Antonenko, S., Xu, X.-L., Trinchieri, G., O'Garra, A., & Liu, Y.-J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020045 · Cited by 524
Belz, G. T., Behrens, G. M. N., Smith, C. M., Miller, J. F. A. P., Jones, C., Lejon, K., Fathman, C. G., Mueller, S. N., Shortman, K., Carbone, F. R., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020861 · Cited by 467
Munn, D. H., Sharma, M. D., & Mellor, A. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4100 · Cited by 457
Self-citationMellor, A. L., Baban, B., Chandler, P., Marshall, B., Jhaver, K., Hansen, A., Koni, P. A., Iwashima, M., & Munn, D. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1652 · Cited by 455
Self-citationO'Keeffe, M., Hochrein, H., Vremec, D., Caminschi, I., Miller, J. L., Anders, E. M., Wu, L., Lahoud, M. H., Henri, S., Scott, B., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021031 · Cited by 368
Asselin-Paturel, C., Brizard, G., Pin, J.-J., Brière, F., & Trinchieri, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6466 · Cited by 360
Cells Expressing Indoleamine 2,3-Dioxygenase Inhibit T Cell Responses
Mellor, A. L., Keskin, D. B., Johnson, T., Chandler, P., & Munn, D. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.3771 · Cited by 348
Self-citationDO11.10 and OT-II T Cells Recognize a C-Terminal Ovalbumin 323–339 Epitope
Robertson, J. M., Jensen, P. E., & Evavold, B. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4706 · Cited by 330
Immunology at the Maternal-Fetal Interface: Lessons for T Cell Tolerance and Suppression
Mellor, A. L., & Munn, D. H. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.367 · Cited by 286
Self-citationBaban, B., Chandler, P., McCool, D., Marshall, B., Munn, D. H., & Mellor, A. L. (2004) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2003.11.003 · Cited by 274
Self-citationFunctional expression of indoleamine 2,3-dioxygenase by murine CD8α+ dendritic cells
Fallarino, F., Vacca, C., Orabona, C., Belladonna, M. L., Bianchi, R., Marshall, B., Keskin, D. B., Mellor, A. L., Fioretti, M. C., Grohmann, U., et al. (2002) · International Immunology · doi:10.1093/intimm/14.1.65 · Cited by 246
Self-citationMartı́n, P., del Hoyo, G. M., Anjuère, F., Arias, C. F., Vargas, H. H., Fernández-L, A., Parrillas, V., & Ardavı́n, C. (2002) · Blood · doi:10.1182/blood.v100.2.383 · Cited by 239
Brawand, P., Fitzpatrick, D. R., Greenfield, B. W., Brasel, K., Maliszewski, C. R., & De Smedt, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6711 · Cited by 238
Kronin, V, Winkel, K., Süss, G., Kelso, A., Heath, W., Kirberg, J., von Boehmer, H., & Shortman, K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.9.3819 · Cited by 225
Bilsborough, J., George, T. C., Norment, A., & Viney, J. L. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01606.x · Cited by 225
The Lymphoid Past of Mouse Plasmacytoid Cells and Thymic Dendritic Cells
Corcoran, L., Ferrero, I., Vremec, D., Lucas, K., Waithman, J., O’Keeffe, M., Wu, L., Wilson, A., & Shortman, K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.4926 · Cited by 206
Tryptophan Catabolism and Regulation of Adaptive Immunity
Mellor, A. L., & Munn, D. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.5809 · Cited by 199
Self-citationRegulatory T Cells Overexpress a Subset of Th2 Gene Transcripts
Zelenika, D., Adams, E., Humm, S., Graca, L., Thompson, S., Cobbold, S. P., & Waldmann, H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1069 · Cited by 173
B Cells Directly Tolerize CD8+ T Cells
Bennett, S. R. M., Carbone, F., Toy, T., Miller, J. F. A. P., & Heath, W. R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.1977 · Cited by 158
CD40L Blockade Prevents Autoimmune Diabetes by Induction of Bitypic NK/DC Regulatory Cells
Homann, D., Jahreis, A., Wolfe, T., Hughes, A. C., Coon, B., van Stipdonk, M. J. B., Prilliman, K. R., Schoenberger, S. P., & von Herrath, M. G. (2002) · Immunity · doi:10.1016/s1074-7613(02)00290-x · Cited by 152
Zélénika, D., Adams, E., Mellor, A. L., Simpson, E., Chandler, P., Stockinger, B., Waldmann, H., & Cobbold, S. P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1868 · Cited by 143
Self-citationCD40 Ligation Ablates the Tolerogenic Potential of Lymphoid Dendritic Cells
Grohmann, U., Fallarino, F., Silla, S., Bianchi, R., Belladonna, M. L., Vacca, C., Micheletti, A., Fioretti, M. C., & Puccetti, P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.277 · Cited by 131
Scott, D. M., Addey, C., Ellis, P., James, E., Mitchell, M. J., Saut, N., Jurčević, S., & Simpson, E. (2000) · Immunity · doi:10.1016/s1074-7613(00)80221-6 · Cited by 125
Immature and Mature CD8α+ Dendritic Cells Prolong the Survival of Vascularized Heart Allografts
O’Connell, P. J., Li, W., Wang, Z., Specht, S. M., Logar, A., & Thomson, A. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.143 · Cited by 118
When ligand becomes receptor—tolerance via B7 signaling on DCs
Finger, E. B., & Bluestone, J. A. (2002) · Nature Immunology · doi:10.1038/ni1102-1056 · Cited by 115
The role of CD4+ T‐cell subsets in determining transplantation rejection or tolerance
Zélénika, D., Adams, E., Humm, S., Lin, C., Waldmann, H., & Cobbold, S. P. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820113.x · Cited by 113
The Ins and Outs of Body Surface Immunology
Hayday, A., & Viney, J. L. (2000) · Science · doi:10.1126/science.290.5489.97 · Cited by 57
Cited by
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
“inhibition of T cells but also induces a DCs inhibitory phenotype (Butte et al., 2007; Mellor et al., 2004).”
BackgroundIdo expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
Self-citationButte, M. J., Keir, M. E., Phamduy, T. B., Sharpe, A. H., & Freeman, G. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.016 · Cited by 1,732
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
Immune checkpoint signaling and cancer immunotherapy
He, X., & Xu, C. (2020) · Cell Research · doi:10.1038/s41422-020-0343-4 · Cited by 1,371
Metadata
- Authors
- Mellor, A. L.
- Venue
- International Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08-31
- Volume
- 16
- Issue
- 10
- Pages
- 1391-1401
- ISSN
- 0953-8178 (ISSN-L)
- 1460-2377
- OpenAlex
- W2123654285
- Cited by
- 288
- References
- 43
- FWCI
- 8.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.